Cognitive-behavioral and mindfulness-based therapies for mental health and quality of life of breast cancer patients: a meta-analysis of randomized controlled trials.
{"title":"Cognitive-behavioral and mindfulness-based therapies for mental health and quality of life of breast cancer patients: a meta-analysis of randomized controlled trials.","authors":"Ruiyi Su, Ruixiang Wang, Zhuyi Li, Yunyun Wang, Xiaoye Zhao, Yihan Sun, Jingwei Ni, Yichun Zhu, Jie Luan, Guangyu Tian, Tian Tian","doi":"10.1007/s10147-025-02875-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To evaluate the effects of cognitive-behavioral therapy (CBT) and mindfulness-based therapy (MBT), individually and in combination, on alleviating anxiety and depression, and improving quality of life (QoL) in breast cancer patients.</p><p><strong>Methods: </strong>We searched PubMed and EMBASE for articles published up to April 6, 2025, using the keywords \"randomized controlled trials (RCTs)\", \"cognitive-behavioral therapy\", \"mindfulness-based therapy\", and \"breast cancer\". Pooled effects were expressed as standardized mean differences (SMDs) and 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Fifty-one RCTs were included. Compared with controls (usual care, wait-list control, etc.), CBT and MBT (analyzed separately or in combination) demonstrated significant benefits. The SMDs (95% CIs) were as follows: anxiety [CBT ( - 0.33, - 0.52 to - 0.14); MBT ( - 0.80, - 1.16 to - 0.45); combined ( - 0.55, - 0.74 to - 0.37)], depression [CBT ( - 0.31, - 0.49 to - 0.14); MBT ( - 0.80, - 1.12 to - 0.48); combined ( - 0.55, - 0.73 to - 0.37)] and QoL [CBT (0.38, 0.15 to 0.62); MBT (0.33, 0.11 to 0.55); combined (0.37, 0.20 to 0.53)]. MBT showed significantly greater efficacy than CBT for anxiety (p = 0.020) and depression (p = 0.009). Pooled effects of CBT and MBT were stronger for group-based and longer duration interventions (all outcomes), with effects on depression and QoL being especially strong in Asians. Face-to-face CBT outperformed internet-delivered CBT across all outcomes.</p><p><strong>Conclusion: </strong>CBT and MBT, individually and combined, are effective for anxiety, depression, and QoL in breast cancer patients, with MBT demonstrating superior efficacy for anxiety and depression. The selection of psychological treatments for breast cancer patients should consider intervention method, ethnicity, intervention duration, and delivery format.</p>","PeriodicalId":13869,"journal":{"name":"International Journal of Clinical Oncology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10147-025-02875-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To evaluate the effects of cognitive-behavioral therapy (CBT) and mindfulness-based therapy (MBT), individually and in combination, on alleviating anxiety and depression, and improving quality of life (QoL) in breast cancer patients.
Methods: We searched PubMed and EMBASE for articles published up to April 6, 2025, using the keywords "randomized controlled trials (RCTs)", "cognitive-behavioral therapy", "mindfulness-based therapy", and "breast cancer". Pooled effects were expressed as standardized mean differences (SMDs) and 95% confidence intervals (CIs).
Results: Fifty-one RCTs were included. Compared with controls (usual care, wait-list control, etc.), CBT and MBT (analyzed separately or in combination) demonstrated significant benefits. The SMDs (95% CIs) were as follows: anxiety [CBT ( - 0.33, - 0.52 to - 0.14); MBT ( - 0.80, - 1.16 to - 0.45); combined ( - 0.55, - 0.74 to - 0.37)], depression [CBT ( - 0.31, - 0.49 to - 0.14); MBT ( - 0.80, - 1.12 to - 0.48); combined ( - 0.55, - 0.73 to - 0.37)] and QoL [CBT (0.38, 0.15 to 0.62); MBT (0.33, 0.11 to 0.55); combined (0.37, 0.20 to 0.53)]. MBT showed significantly greater efficacy than CBT for anxiety (p = 0.020) and depression (p = 0.009). Pooled effects of CBT and MBT were stronger for group-based and longer duration interventions (all outcomes), with effects on depression and QoL being especially strong in Asians. Face-to-face CBT outperformed internet-delivered CBT across all outcomes.
Conclusion: CBT and MBT, individually and combined, are effective for anxiety, depression, and QoL in breast cancer patients, with MBT demonstrating superior efficacy for anxiety and depression. The selection of psychological treatments for breast cancer patients should consider intervention method, ethnicity, intervention duration, and delivery format.
期刊介绍：
The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
